Cytek Biosciences, Inc. (CTKB)
4.735
+0.12
(+2.49%)
USD |
NASDAQ |
Sep 09, 16:00
4.735
0.00 (0.00%)
After-Hours: 16:02
Cytek Biosciences EPS Diluted (Quarterly) : -0.0939 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0939 |
| March 31, 2026 | -0.1466 |
| December 31, 2025 | -0.3439 |
| September 30, 2025 | -0.043 |
| June 30, 2025 | -0.044 |
| March 31, 2025 | -0.0888 |
| December 31, 2024 | 0.0746 |
| September 30, 2024 | 0.0071 |
| June 30, 2024 | -0.0794 |
| March 31, 2024 | -0.0471 |
| December 31, 2023 | 0.0421 |
| September 30, 2023 | -0.0474 |
| June 30, 2023 | -0.0323 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.0502 |
| December 31, 2022 | 0.0261 |
| September 30, 2022 | 0.012 |
| June 30, 2022 | -0.0044 |
| March 31, 2022 | -0.0151 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0026 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0043 |
| September 30, 2020 | 0.0108 |
| June 30, 2020 | 0.0409 |
| March 31, 2020 | -0.0063 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
| Danaher Corp. | 1.230 |
| Harvard Bioscience, Inc. | -0.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.16M |
| Revenue (Quarterly) | 48.14M |
| Total Expenses (Quarterly) | 60.30M |
| Enterprise Value | 373.70M |
| Gross Profit Margin (Quarterly) | 58.87% |
| Profit Margin (Quarterly) | -25.26% |
| Earnings Yield | -13.25% |
| Normalized Earnings Yield | -13.07 |